Respiratory, Inflammation & Autoimmunity

Taming inflammation, rebalancing immunity

The consequences of an immune system out of balance can be disastrous—debilitating respiratory, inflammatory and autoimmune diseases. Our scientists have built one of the richest, most diverse immunomodulatory portfolios in the industry, focused on conditions from asthma and lupus to multiple sclerosis and rheumatoid arthritis.


Our Pipeline

Respiratory

Phase 1

Phase 1

Phase 2

Phase 2

  • tezepelumab asthma/atopic dermatitis

Phase 3

Phase 3

  • benralizumab CALIMA SIROCCO ZONDA BISE BORA GREGALE severe asthma
  • benralizumab TERRANOVA GALATHEA COPD
  • tralokinumab STRATOS 1,2 TROPOS MESOS severe asthma

Respiratory News

Respiratory Publications


Join us at MedImmune

Our Great Place to Work strategic initiative offers a dynamic environment that fosters collaboration and innovation. We attract top minds, and we do what it takes to nurture and build talent.